Received Sep 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
IM/intramuscular second dose not administered
Hepatitis C no second opinion requested
Add
Fda request submitted to verify that I am complying with such request through post-marketing surveillance.
Ibuprofen
Pfizer proprietary knowledge witheld by patient